ID   KAMA_CLOSU              Reviewed;         416 AA.
AC   Q9XBQ8;
DT   24-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   27-MAY-2015, entry version 68.
DE   RecName: Full=L-lysine 2,3-aminomutase;
DE            Short=LAM;
DE            EC=5.4.3.2;
DE   AltName: Full=KAM;
GN   Name=kamA;
OS   Clostridium subterminale.
OC   Bacteria; Firmicutes; Clostridia; Clostridiales; Clostridiaceae;
OC   Clostridium.
OX   NCBI_TaxID=1550;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 1-16; 342-389
RP   AND 401-416, AND CHARACTERIZATION.
RC   STRAIN=SB4;
RX   PubMed=10629195; DOI=10.1128/JB.182.2.469-476.2000;
RA   Ruzicka F.J., Lieder K.W., Frey P.A.;
RT   "Lysine 2,3-aminomutase from Clostridium subterminale SB4: mass
RT   spectral characterization of cyanogen bromide-treated peptides and
RT   cloning, sequencing, and expression of the gene kamA in Escherichia
RT   coli.";
RL   J. Bacteriol. 182:469-476(2000).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES,
RP   AND ENZYME REGULATION.
RX   PubMed=5438361;
RA   Chirpich T.P., Zappia V., Costilow R.N., Barker H.A.;
RT   "Lysine 2,3-aminomutase. Purification and properties of a pyridoxal
RT   phosphate and S-adenosylmethionine-activated enzyme.";
RL   J. Biol. Chem. 245:1778-1789(1970).
RN   [3]
RP   SUBUNIT.
RC   STRAIN=SB4;
RX   PubMed=2019591;
RA   Song K.B., Frey P.A.;
RT   "Molecular properties of lysine-2,3-aminomutase.";
RL   J. Biol. Chem. 266:7651-7655(1991).
RN   [4]
RP   FUNCTION, COFACTOR, AND ENZYME REGULATION.
RX   PubMed=1850415;
RA   Petrovich R.M., Ruzicka F.J., Reed G.H., Frey P.A.;
RT   "Metal cofactors of lysine-2,3-aminomutase.";
RL   J. Biol. Chem. 266:7656-7660(1991).
RN   [5]
RP   FUNCTION, COFACTOR, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=1329954; DOI=10.1021/bi00159a019;
RA   Petrovich R.M., Ruzicka F.J., Reed G.H., Frey P.A.;
RT   "Characterization of iron-sulfur clusters in lysine 2,3-aminomutase by
RT   electron paramagnetic resonance spectroscopy.";
RL   Biochemistry 31:10774-10781(1992).
RN   [6]
RP   ENZYME REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=11370852; DOI=10.1006/abbi.2001.2261;
RA   Miller J., Bandarian V., Reed G.H., Frey P.A.;
RT   "Inhibition of lysine 2,3-aminomutase by the alternative substrate 4-
RT   thialysine and characterization of the 4-thialysyl radical
RT   intermediate.";
RL   Arch. Biochem. Biophys. 387:281-288(2001).
RN   [7]
RP   MUTAGENESIS OF GLU-86; ASP-96; ARG-130; ARG-134; ARG-135; ARG-136;
RP   ASP-165; ASP-172; GLU-236; ASP-293 AND ASP-330.
RX   PubMed=17042481; DOI=10.1021/bi061329l;
RA   Chen D., Frey P.A., Lepore B.W., Ringe D., Ruzicka F.J.;
RT   "Identification of structural and catalytic classes of highly
RT   conserved amino acid residues in lysine 2,3-aminomutase.";
RL   Biochemistry 45:12647-12653(2006).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) IN COMPLEX WITH SUBSTRATE AND
RP   COFACTOR.
RC   STRAIN=SB4;
RX   PubMed=16166264; DOI=10.1073/pnas.0505726102;
RA   Lepore B.W., Ruzicka F.J., Frey P.A., Ringe D.;
RT   "The X-ray crystal structure of lysine-2,3-aminomutase from
RT   Clostridium subterminale.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:13819-13824(2005).
CC   -!- FUNCTION: Catalyzes the interconversion of L-alpha-lysine and L-
CC       beta-lysine. {ECO:0000269|PubMed:1329954,
CC       ECO:0000269|PubMed:1850415, ECO:0000269|PubMed:5438361}.
CC   -!- CATALYTIC ACTIVITY: L-lysine = (3S)-3,6-diaminohexanoate.
CC       {ECO:0000269|PubMed:5438361}.
CC   -!- COFACTOR:
CC       Name=[4Fe-4S] cluster; Xref=ChEBI:CHEBI:49883;
CC       Note=Binds 1 [4Fe-4S] cluster per subunit. The cluster is
CC       coordinated with 3 cysteines and an exchangeable S-adenosyl-L-
CC       methionine.;
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC   -!- COFACTOR:
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC       Note=Binds 1 Co(2+) ion per subunit.;
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC       Note=Binds 1 zinc ion per subunit.;
CC   -!- ENZYME REGULATION: The enzyme is activated by S-adenosyl-
CC       methionine. Activity is dependent on the levels of Fe(2+), S(2-)
CC       and Co(2+). Activity is stimulated by addition of EDTA. S-
CC       adenosylhomocysteine competitively inhibits the activity whereas
CC       5'-methylthioadenosine is not inhibitory in the presence of S-
CC       adenosylmethionine. Competitively inhibited by 4-thialysine.
CC       Inhibited by sodium borohydride (1 mM) when added with 2 mM
CC       dithionate. Moderately inhibited by beta-mercaptoethanol (30 mM)
CC       along with dithionate. Higher concentrations of Fe(2+) partially
CC       inhibit the activity and Co(2+) at 1 mM is a strong inhibitor.
CC       Hydroxylamine, isonicotinic acid hydrazide inhibit effectively, in
CC       addition, hydrazine, D-penicillamine and D-cycloserine are also
CC       inhibitory at high concentrations. {ECO:0000269|PubMed:11370852,
CC       ECO:0000269|PubMed:1850415, ECO:0000269|PubMed:5438361}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=6.6 uM for L-lysine {ECO:0000269|PubMed:11370852,
CC         ECO:0000269|PubMed:1329954, ECO:0000269|PubMed:5438361};
CC         KM=28 nM for adenosylmethionine {ECO:0000269|PubMed:11370852,
CC         ECO:0000269|PubMed:1329954, ECO:0000269|PubMed:5438361};
CC         KM=1.4 mM for 4-thialysine {ECO:0000269|PubMed:11370852,
CC         ECO:0000269|PubMed:1329954, ECO:0000269|PubMed:5438361};
CC         Vmax=0.19 umol/min/mg enzyme with 4-thialysine as substrate (at
CC         37 degrees Celsius and pH 8) {ECO:0000269|PubMed:11370852,
CC         ECO:0000269|PubMed:1329954, ECO:0000269|PubMed:5438361};
CC       pH dependence:
CC         Optimum pH is 8.0. Displays half maximal activity between pH 6.0
CC         and 9.8. {ECO:0000269|PubMed:11370852,
CC         ECO:0000269|PubMed:1329954, ECO:0000269|PubMed:5438361};
CC       Redox potential:
CC         E(0) is between -336 and -370 mV for 4Fe-4S cluster.
CC         {ECO:0000269|PubMed:11370852, ECO:0000269|PubMed:1329954,
CC         ECO:0000269|PubMed:5438361};
CC       Temperature dependence:
CC         Optimum temperature is 37 degrees Celsius. It has strong
CC         activity at 37 degrees Celsius but is reversibly inactivated in
CC         temperatures between 37 and 65 degrees Celsius. Minimal loss of
CC         activity is observed in enzyme stored at -10 degrees Celsius in
CC         the presence of 15% glycerol. {ECO:0000269|PubMed:11370852,
CC         ECO:0000269|PubMed:1329954, ECO:0000269|PubMed:5438361};
CC   -!- PATHWAY: Amino-acid degradation; L-lysine degradation via acetate
CC       pathway.
CC   -!- SUBUNIT: Homohexamer; trimer of dimers. Forms a homotetramer in
CC       crystal. {ECO:0000269|PubMed:16166264,
CC       ECO:0000269|PubMed:2019591}.
CC   -!- SIMILARITY: Belongs to the radical SAM superfamily. KamA family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF159146; AAD43134.1; -; Genomic_DNA.
DR   PDB; 2A5H; X-ray; 2.10 A; A/B/C/D=1-416.
DR   PDBsum; 2A5H; -.
DR   ProteinModelPortal; Q9XBQ8; -.
DR   SMR; Q9XBQ8; 3-412.
DR   BioCyc; MetaCyc:MONOMER-12270; -.
DR   BioCyc; RETL1328306-WGS:GSTH-4135-MONOMER; -.
DR   BRENDA; 5.4.3.2; 1523.
DR   UniPathway; UPA00870; -.
DR   EvolutionaryTrace; Q9XBQ8; -.
DR   GO; GO:0051539; F:4 iron, 4 sulfur cluster binding; IEA:UniProtKB-KW.
DR   GO; GO:0050066; F:lysine 2,3-aminomutase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019475; P:L-lysine catabolic process to acetate; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.20.20.70; -; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR025895; LAM_C_dom.
DR   InterPro; IPR003739; Lys_aminomutase/Glu_NH3_mut.
DR   InterPro; IPR022459; Lysine_aminomutase.
DR   InterPro; IPR007197; rSAM.
DR   Pfam; PF12544; LAM_C; 1.
DR   Pfam; PF04055; Radical_SAM; 1.
DR   PIRSF; PIRSF004911; DUF160; 1.
DR   TIGRFAMs; TIGR03820; lys_2_3_AblA; 1.
DR   TIGRFAMs; TIGR00238; TIGR00238; 1.
PE   1: Evidence at protein level;
KW   3D-structure; 4Fe-4S; Cobalt; Direct protein sequencing; Iron;
KW   Iron-sulfur; Isomerase; Metal-binding; Pyridoxal phosphate;
KW   S-adenosyl-L-methionine; Zinc.
FT   CHAIN         1    416       L-lysine 2,3-aminomutase.
FT                                /FTId=PRO_0000172287.
FT   METAL       125    125       Iron-sulfur (4Fe-4S-S-AdoMet).
FT   METAL       129    129       Iron-sulfur (4Fe-4S-S-AdoMet).
FT   METAL       132    132       Iron-sulfur (4Fe-4S-S-AdoMet).
FT   METAL       268    268       Zinc.
FT   METAL       375    375       Zinc.
FT   METAL       377    377       Zinc.
FT   METAL       380    380       Zinc.
FT   MOD_RES     337    337       N6-(pyridoxal phosphate)lysine.
FT   MUTAGEN      86     86       E->Q: Reduction in activity. Decrease in
FT                                iron and sulfide and PLP content.
FT                                {ECO:0000269|PubMed:17042481}.
FT   MUTAGEN      96     96       D->N: Reduction in activity. Decrease in
FT                                iron and sulfide and PLP content.
FT                                {ECO:0000269|PubMed:17042481}.
FT   MUTAGEN     130    130       R->Q,K: Complete loss of activity.
FT                                Decrease in iron and sulfide but not PLP
FT                                content. Destabilise the iron-sulfur
FT                                centers. {ECO:0000269|PubMed:17042481}.
FT   MUTAGEN     134    134       R->K: Complete loss of activity.
FT                                Significant decrease in iron and sulfide
FT                                and PLP content.
FT                                {ECO:0000269|PubMed:17042481}.
FT   MUTAGEN     134    134       R->Q: Complete loss of activity. Slight
FT                                decrease in iron and sulfide and PLP
FT                                content. {ECO:0000269|PubMed:17042481}.
FT   MUTAGEN     135    135       R->K: Reduction in activity. Decrease in
FT                                iron and sulfide and PLP content.
FT                                {ECO:0000269|PubMed:17042481}.
FT   MUTAGEN     135    135       R->Q: Reduction in activity. Significant
FT                                decrease in iron and sulfide and PLP
FT                                content. {ECO:0000269|PubMed:17042481}.
FT   MUTAGEN     136    136       R->Q: Reduction in activity. Significant
FT                                decrease in iron and sulfide and PLP
FT                                content. {ECO:0000269|PubMed:17042481}.
FT   MUTAGEN     165    165       D->N: Significant reduction in activity.
FT                                Decrease in iron and sulfide and PLP
FT                                content. {ECO:0000269|PubMed:17042481}.
FT   MUTAGEN     172    172       D->N: Complete loss of activity. Decrease
FT                                in iron and sulfide and PLP content.
FT                                Destabilise the iron-sulfur centers.
FT                                {ECO:0000269|PubMed:17042481}.
FT   MUTAGEN     236    236       E->Q: Significant reduction in activity.
FT                                Decrease in iron and sulfide and PLP
FT                                content. {ECO:0000269|PubMed:17042481}.
FT   MUTAGEN     293    293       D->N: Complete loss of activity. Decrease
FT                                in iron and sulfide and PLP content.
FT                                {ECO:0000269|PubMed:17042481}.
FT   MUTAGEN     330    330       D->A,N: Complete loss of activity.
FT                                Decrease in iron and sulfide and PLP
FT                                content. {ECO:0000269|PubMed:17042481}.
FT   HELIX         4      8       {ECO:0000244|PDB:2A5H}.
FT   HELIX        14     17       {ECO:0000244|PDB:2A5H}.
FT   HELIX        20     25       {ECO:0000244|PDB:2A5H}.
FT   HELIX        31     35       {ECO:0000244|PDB:2A5H}.
FT   HELIX        42     49       {ECO:0000244|PDB:2A5H}.
FT   HELIX        61     64       {ECO:0000244|PDB:2A5H}.
FT   HELIX        75     80       {ECO:0000244|PDB:2A5H}.
FT   HELIX        84     87       {ECO:0000244|PDB:2A5H}.
FT   STRAND       94     96       {ECO:0000244|PDB:2A5H}.
FT   TURN        100    102       {ECO:0000244|PDB:2A5H}.
FT   STRAND      113    123       {ECO:0000244|PDB:2A5H}.
FT   TURN        133    139       {ECO:0000244|PDB:2A5H}.
FT   STRAND      140    144       {ECO:0000244|PDB:2A5H}.
FT   HELIX       147    158       {ECO:0000244|PDB:2A5H}.
FT   STRAND      165    171       {ECO:0000244|PDB:2A5H}.
FT   HELIX       178    189       {ECO:0000244|PDB:2A5H}.
FT   STRAND      196    200       {ECO:0000244|PDB:2A5H}.
FT   HELIX       203    206       {ECO:0000244|PDB:2A5H}.
FT   HELIX       208    210       {ECO:0000244|PDB:2A5H}.
FT   HELIX       213    219       {ECO:0000244|PDB:2A5H}.
FT   HELIX       220    222       {ECO:0000244|PDB:2A5H}.
FT   STRAND      224    229       {ECO:0000244|PDB:2A5H}.
FT   HELIX       234    236       {ECO:0000244|PDB:2A5H}.
FT   HELIX       239    250       {ECO:0000244|PDB:2A5H}.
FT   STRAND      255    260       {ECO:0000244|PDB:2A5H}.
FT   TURN        263    265       {ECO:0000244|PDB:2A5H}.
FT   HELIX       269    281       {ECO:0000244|PDB:2A5H}.
FT   STRAND      284    290       {ECO:0000244|PDB:2A5H}.
FT   HELIX       299    301       {ECO:0000244|PDB:2A5H}.
FT   HELIX       305    313       {ECO:0000244|PDB:2A5H}.
FT   HELIX       321    323       {ECO:0000244|PDB:2A5H}.
FT   STRAND      326    331       {ECO:0000244|PDB:2A5H}.
FT   TURN        332    335       {ECO:0000244|PDB:2A5H}.
FT   STRAND      336    339       {ECO:0000244|PDB:2A5H}.
FT   STRAND      345    349       {ECO:0000244|PDB:2A5H}.
FT   STRAND      352    356       {ECO:0000244|PDB:2A5H}.
FT   STRAND      362    366       {ECO:0000244|PDB:2A5H}.
FT   TURN        378    382       {ECO:0000244|PDB:2A5H}.
FT   HELIX       390    395       {ECO:0000244|PDB:2A5H}.
FT   STRAND      400    402       {ECO:0000244|PDB:2A5H}.
FT   HELIX       408    410       {ECO:0000244|PDB:2A5H}.
SQ   SEQUENCE   416 AA;  47102 MW;  6C3602E5B87E25A1 CRC64;
     MINRRYELFK DVSDADWNDW RWQVRNRIET VEELKKYIPL TKEEEEGVAQ CVKSLRMAIT
     PYYLSLIDPN DPNDPVRKQA IPTALELNKA AADLEDPLHE DTDSPVPGLT HRYPDRVLLL
     ITDMCSMYCR HCTRRRFAGQ SDDSMPMERI DKAIDYIRNT PQVRDVLLSG GDALLVSDET
     LEYIIAKLRE IPHVEIVRIG SRTPVVLPQR ITPELVNMLK KYHPVWLNTH FNHPNEITEE
     STRACQLLAD AGVPLGNQSV LLRGVNDCVH VMKELVNKLV KIRVRPYYIY QCDLSLGLEH
     FRTPVSKGIE IIEGLRGHTS GYCVPTFVVD APGGGGKTPV MPNYVISQSH DKVILRNFEG
     VITTYSEPIN YTPGCNCDVC TGKKKVHKVG VAGLLNGEGM ALEPVGLERN KRHVQE
//
